[1]
I. M. Shamkh, D. Pratiwi, H. S. Omar, and N. E.-H. A. Reyad, “In Silico Study for Similar FDA Approved Drugs as Inhibitors of SARS-CoV-2 Spike and the Host Receptor Proteins”, J Mol Docking, vol. 1, no. 2, pp. 49–58, Dec. 2021.